ZERO CANDIDA TECHNOLOGIES INC (ZCT.V)

0.3600

+0.0450

+(14.29%)

At close: April 28 at 11:29:18 AM EDT

Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights

Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing women's health, reports financial results and key business achievements for the year ended December 31, 2024. These results are presented in accordance with the International Financial Reporting Standard (IFRS) as issued by the International Accounting Standards Board. This release should be read in conjunction with the Company's audited consolidated fi

PR Newswire 26 days ago

ZCTFF
Zero Candida Commences Trading on OTCQB Market

Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing women's health, is pleased to announce that its common shares will commence trading today on the OTCQB Venture Market under the ticker symbol "ZCTFF". The Company will continue to trade on the TSX Venture Exchange and Frankfurt Stock Exchange.

PR Newswire last month

ZCTFF
Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030

A market analysis made by Moore Financial Consulting published today estimate the global market for Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, will reach over USD 2 billion by 2030, with a compound annual growth rate of 5.25% globally and 3.9% in North America and 4.2% in Europe.

PR Newswire 2 months ago

9L2.F

ZCT.V
+14.29%
Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar

Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, is pleased to announce that its shares are now successfully listed on the Frankfurt Stock Exchange (FSE) under the trading symbol "9L2". Their listing marks a significant milestone for the Company as it expands its global presence, now cross-listed on both the TSX Venture Exchange and the FSE, providing increased visibility and acce

PR Newswire 3 months ago

ZCT.V
+14.29%
9L2.F
Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, announces plans to complete preclinical studies for FDA submission by Q3 2025. In accordance with FDA requirements, the company is preparing to conduct a full preclinical study of its final human-use device in up to 24 additional sheep.

PR Newswire 3 months ago

ZCT.V
+14.29%
9L2.F
Zero Candida Receives South African Patent for its ZC- 01 device

Zero Candida (the "Company" or "ZC") (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received a final patent from South Africa PCT patent PCT-IL 2023050243 in South Africa. In addition, the company is actively pursuing a global patent portfolio with applications filed worldwide including in the United States, Brazil, and Europe.

PR Newswire 4 months ago

ZCT.V
+14.29%
Zero Candida Technologies Inc. (ZCT) Opens the Market

Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.Cannot view this video? Visit:https://www.youtube.com/watch?v=4Rj-qOUi3-sZero Candida Technologies, Inc. (ZCT), is a medical device c

Newsfile 4 months ago

ZCT.V
+14.29%
Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)

Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce full Transaction and Being Trading on November 25th on the TSX Venture Exchange (Canada) symbol : ZCT.

PR Newswire 4 months ago

ZCT.V
+14.29%

Performance Overview

Return	ZCT.V	S&P/TSX Composite index (^GSPTSE)
YTD	-32.08%	+0.72%
1-Year	-82.86%	+12.88%
3-Year	-82.86%	+17.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

ZERO CANDIDA TECHNOLOGIES INC (ZCT.V)

Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights

Zero Candida Commences Trading on OTCQB Market

Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030

Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar

Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Receives South African Patent for its ZC- 01 device

Zero Candida Technologies Inc. (ZCT) Opens the Market

Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)

Performance Overview